N-[(3R,5S)-1-methylsulfonyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;(3S,5R)-1-methyl-5-(trifluoromethyl)piperidin-3-amine;N-[(3R,5S)-1-methyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)-N-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]pyridin-2-amine
C61H69F12N19O2S — CID 159426855
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3R,5S)-1-methylsulfonyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;(3S,5R)-1-methyl-5-(trifluoromethyl)piperidin-3-amine;N-[(3R,5S)-1-methyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)-N-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]pyridin-2-amine
N-[(3R,5S)-1-methylsulfonyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;(3S,5R)-1-methyl-5-(trifluoromethyl)piperidin-3-amine;N-[(3R,5S)-1-methyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)-N-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]pyridin-2-amine (PubChem CID 159426855) has the molecular formula C61H69F12N19O2S and a molecular weight of 1360.40 g/mol. Its IUPAC name is N-[(3R,5S)-1-methylsulfonyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;(3S,5R)-1-methyl-5-(trifluoromethyl)piperidin-3-amine;N-[(3R,5S)-1-methyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)-N-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]pyridin-2-amine.
Molecular Properties
| Compound Name | N-[(3R,5S)-1-methylsulfonyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;(3S,5R)-1-methyl-5-(trifluoromethyl)piperidin-3-amine;N-[(3R,5S)-1-methyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)-N-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]pyridin-2-amine |
|---|---|
| PubChem CID | 159426855 |
| Molecular Formula | C61H69F12N19O2S |
| Molecular Weight | 1360.40 g/mol |
| Exact Mass | 1359.54 |
| IUPAC Name | N-[(3R,5S)-1-methylsulfonyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;(3S,5R)-1-methyl-5-(trifluoromethyl)piperidin-3-amine;N-[(3R,5S)-1-methyl-5-(trifluoromethyl)piperidin-3-yl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-2-amine;3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)-N-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]pyridin-2-amine |
| SMILES | CN1C[C@@H](N)C[C@@H](C(F)(F)F)C1.CN1C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C[C@H](C(F)(F)F)C1.CS(=O)(=O)N1C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C[C@H](C(F)(F)F)C1.FC(F)(F)[C@@H]1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1 |
| InChI | InChI=1S/C18H19F3N6O2S.C18H19F3N6.C18H18F3N5.C7H13F3N2/c1-30(28,29)27-9-11(18(19,20)21)7-12(10-27)25-16-13(3-2-5-22-16)15-8-24-17-14(26-15)4-6-23-17;1-27-9-11(18(19,20)21)7-12(10-27)25-16-13(3-2-5-22-16)15-8-24-17-14(26-15)4-6-23-17;19-18(20,21)11-3-1-4-12(9-11)25-16-13(5-2-7-22-16)15-10-24-17-14(26-15)6-8-23-17;1-12-3-5(7(8,9)10)2-6(11)4-12/h2-6,8,11-12H,7,9-10H2,1H3,(H,22,25)(H,23,24);2-6,8,11-12H,7,9-10H2,1H3,(H,22,25)(H,23,24);2,5-8,10-12H,1,3-4,9H2,(H,22,25)(H,23,24);5-6H,2-4,11H2,1H3/t3*11-,12+;5-,6+/m0011/s1 |
| InChIKey | LQLXJGIAOUSJSE-MTRBDEBZSA-N |
| XLogP | 11.34 |
| TPSA | 269.35 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 95 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1360.40 |
| LogP ≤ 5 | 11.34 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159426855 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.